(Q35611909)

24504444

9 August 2017

title

Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma (English)

1 reference

9 August 2017

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Jochen Utikal

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

B Schilling

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

W Sondermann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

F Zhao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

E Livingstone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A Sucker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

H Zelba

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

B Weide

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

U Trefzer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

T Wilhelm

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

C Loquai

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

C Berking

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

J Hassel

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

K C Kähler

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

P Al Ghazal

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

R Gutzmer

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

S M Goldinger

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

L Zimmer

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A Paschen

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

U Hillen

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

D Schadendorf

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

DeCOG

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

6 February 2014

1 reference

9 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

747-753

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials

4 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Which drug, and when, for patients with BRAF-mutant melanoma?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Progression of RAS-mutant leukemia during RAF inhibitor treatment

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competency

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Immunologic functions as prognostic indicators in melanoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Heterogeneity and plasticity of T helper cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Final version of 2009 AJCC melanoma staging and classification

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Interferons, immunity and cancer immunoediting

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

Blocking MAPK signaling downregulates CCL21 in lymphatic endothelial cells and impairs contact hypersensitivity responses.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4433519

25 September 2018

Identifiers

DOI

10.1093/ANNONC/MDT587

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

24504444

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24504444%20AND%20SRC:MED&resulttype=core&format=json